about
Inflammatory breast cancer: what we know and what we need to learnThe Anti-Cancer Effect of Polyphenols against Breast Cancer and Cancer Stem Cells: Molecular MechanismsDevelopmental therapeutics for inflammatory breast cancer: Biology and translational directionsClonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- VinorelbineA comparison of criteria to identify inflammatory breast cancer cases from medical records and the Surveillance, Epidemiology and End Results data base, 2007-2009.Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cellsGeospatial Analysis of Inflammatory Breast Cancer and Associated Community Characteristics in the United States.Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients.Cancer diagnosis in primary careAnalysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients.Underuse of trimodality treatment affects survival for patients with inflammatory breast cancer: an analysis of treatment and survival trends from the National Cancer Database.Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer.Alternate estrogen receptors promote invasion of inflammatory breast cancer cells via non-genomic signalingOverall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosisImmunologic targeting of FOXP3 in inflammatory breast cancer cells.Prevalence of papillomaviruses, polyomaviruses, and herpesviruses in triple-negative and inflammatory breast tumors from algeria compared with other types of breast cancer tumors.High proportion of inflammatory breast cancer in the Population-based Cancer Registry of Gharbiah, Egypt.Survival of inflammatory breast cancer patients compared to non-inflammatory breast cancer patients in EgyptInflammatory breast cancer in north Africa: comparison of clinical and molecular epidemiologic characteristics of patients from Egypt, Tunisia, and MoroccoInflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008.Differences in Reliability of Reproductive History Recall Among Women in North Africa.Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancerInflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer.Residential environment and breast cancer incidence and mortality: a systematic review and meta-analysis.Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients.Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007.Glucocorticoid receptor expression in breast cancer associates with older patient ageInflammatory Breast Carcinoma Presenting with Two Different Patterns of Cutaneous Metastases: Carcinoma Telangiectaticum and Carcinoma Erysipeloides.Importance of hereditary and selected environmental risk factors in the etiology of inflammatory breast cancer: a case-comparison study.Epidemiology of triple negative breast cancersA randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer.A comparison of cholesterol uptake and storage in inflammatory and noninflammatory breast cancer cells.Characterizing inflammatory breast cancer among Arab Americans in the California, Detroit and New Jersey Surveillance, Epidemiology and End Results (SEER) registries (1988-2008).Inflammatory breast carcinomaThe effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cellsChronic inflammation and breast cancer recurrence.Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast Cancer.ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells.Histone deacetylase inhibitors modulate miRNA and mRNA expression, block metaphase, and induce apoptosis in inflammatory breast cancer cellsRisk factors for inflammatory breast cancer and other invasive breast cancers.
P2860
Q27028128-6B7C6362-557E-4953-B3D7-D1795BB9EB96Q28066752-FA2FFF10-DAA2-455D-8B16-05E32D9C2B50Q28075322-51EC8A6C-5811-491F-A1A6-790D0C995BEAQ28554790-94C02428-9266-4B0F-B515-214561838673Q30724470-5E91BFD4-1A9C-4A06-89CC-3BDC793D0C64Q31138996-12156634-9C3C-4BF9-9050-064D003636F8Q33616254-C7C7FEC8-4BEC-46C7-A0DF-2BC1E25CC693Q33618285-CFA9701B-BEAF-457C-A9E0-2CF122129A85Q33622291-11C5CB52-D371-44BE-9D67-DCF1101C3131Q33636065-C63FFE07-1CD3-4225-8F2C-A3FB4380295DQ33796162-589C1190-290C-4546-A965-A8E2CB9274E6Q33829270-8FBD523D-79E0-4C1B-808F-BED5B8862934Q34147662-3C3B54A0-1519-49A8-977F-B7EF19ADE1CBQ34478105-8AA6E3DC-D8F9-40D0-91BC-F01282F58507Q34558393-34657264-7754-451A-A1CF-C4E6406E5931Q34640608-BC1E11FE-D770-44D2-B4F0-CC8974A4BF58Q34769223-0D8D32B5-A50B-4C93-A49A-4CB8579D2D9AQ34917731-FA372EFD-3537-4683-A611-DD3EDCA327D2Q34918207-AA3680FE-9FD3-4397-BD0D-41196ED96A1AQ34918360-0909C94B-225C-4715-B394-BAFAB9492359Q35006619-943E9D9A-EE67-42C1-867B-47813BC0CC61Q35007782-75102F4E-55BD-467C-A2EA-89E1D254E5A6Q35115896-FC1DA3A1-946A-4AEC-B782-324AC63C7DEAQ35413280-D3021AE6-B016-438D-B388-2F7C9EF5BAA5Q35572495-66AD599E-9C82-4FD2-9F81-74E9E4B24922Q35662191-502A5E9A-AB9C-465A-8BE5-525AD7685DD4Q35951359-64E1DEE7-76C4-455C-BA10-137EAAD15729Q36020234-9757E2D1-97AD-490C-9E5E-573BF3A6D0D1Q36031290-B195477D-B159-41B2-AD7A-1D49BB6F4B95Q36386871-29A5637F-B7CF-44EA-B044-428197615BC6Q36514752-2D5138B9-D4D1-4BE8-BD61-F7BE86FFF1C5Q36546465-CB7D8241-9272-47CF-B3E6-99D165DF3654Q36598732-670E1A82-0AAD-49EB-8DD0-B48C41008DCCQ36703133-6404EB1C-ED8E-410C-97B0-0C241F57B2B8Q36725203-FE19793C-0023-4B62-85C5-BDE8CE0DB53DQ36790725-BA2B0EDE-4AD4-4FBA-B84F-85846EA58334Q37015722-95ABCC06-7EBB-4BD1-A772-04E15CDB20DFQ37072265-6E371CA5-4933-4D7E-97E9-FBE2302BB507Q37092688-9703D756-A484-46A6-9F12-47994BC33D20Q37180368-03C28CE7-D1A7-455D-A2BC-724B1B92A047
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Epidemiology of inflammatory breast cancer (IBC).
@ast
Epidemiology of inflammatory breast cancer (IBC).
@en
type
label
Epidemiology of inflammatory breast cancer (IBC).
@ast
Epidemiology of inflammatory breast cancer (IBC).
@en
prefLabel
Epidemiology of inflammatory breast cancer (IBC).
@ast
Epidemiology of inflammatory breast cancer (IBC).
@en
P2093
P2860
P356
P1433
P1476
Epidemiology of inflammatory breast cancer (IBC)
@en
P2093
Catherine Schairer
Kenneth W Hance
Paul H Levine
William F Anderson
P2860
P356
10.3233/BD-2006-22103
P577
2005-01-01T00:00:00Z